Simple Education essential guides Coronary Physiology and Intracoronary Imaging Co-Registration is the premier international course in co-registration. This is the first course specialising in coronary co-registration, and builds on the 6 years of courses which have been run and quickly established as the premier global interventional course in state-of-the-art coronary physiology and intracoronary imaging. The course provides all you need to know to understand coronary physiology from learning the background basics of coronary physiology and imaging to understanding the clinical trial data and implementation of co-registration in the catheter laboratory.
An online teaching resource, the Simple Education application, will give you access to video content from the days' talks, and a raft of other online educational and learning resources which continue your learning experience and connect you with the interventional community after the course finishes.
Dr Justin Davies is a consultant interventional cardiologist at Hammersmith Hospital, Imperial College NHS Trust, London. After training at Imperial College, he won a prestigious BHF research fellowship to study arterial haemodynamics. Since then he has continued to work on the development of mathematical algorithms to aid understanding of large artery physiology and to develop new tools to assess arterial disease. The holder of several patents, he has published widely in the field of hypertension, coronary and large artery physiology and is the winner of many national and international awards. He has several international collaborations, and is the developer of iFR and the co-principal investigator of the ADVISE studies, the DEFINE-FLAIR, ORBITA and DEFINE-PCI studies. Justin also has an interest in renal denervation, and has lead the first-in-man studies to evaluate the safety of this technique to patients with chronic systolic heart failure (REACH studies). Prof Javier Escaned is Consultant Interventional Cardiologist / Associate Professor and Head of Section, Cardiology Department, Hospital Clinico San Carlos (Madrid, Spain). He trained as a cardiologist the United Kingdom (Queen Elizabeth University Hospital, Birmingham and Walsgrave Hospital, Coventry) before moving to the Thoraxcenter / Rotterdam (The Netherlands), where he obtained his PhD degree in 1994. Author of more than 200 scientific articles, books and book chapters on different aspects of interventional cardiology, imaging and physiology, his latest contribution is the textbook “Coronary Stenosis. Imaging, Structure and Physiology”, co-edited with Patrick W Serruys. He is currently co-director or EuroPCR. Some of his additional interests are philosophy, education and music. Prof Carlo Di Mario is currently Professor of Cardiology, University of Florence and Director of the Structural Interventional Cardiology Division of the University Hospital Careggi, Florence, Italy. Previous posts included 15 years as Professor of Clinical Cardiology at Imperial College of Sciences, Medicine & Technology, London and Consultant Cardiologist at the Royal Brompton Hospital. He also practiced at the San Raffaele Hospital, Milan, Italy. He trained in Cardiology at the University of Padova, Italy, but he soon moved for a more in-depth interventional trying at the Thoraxcentre of Rotterdam, the Netherlands, where he also completed a PhD in Intracoronary Ultrasound Imaging and Doppler. He maintains an active clinical involvement performing more than 200 PCI per year in the last 15 years in London with the special interest in the treatment of chronic total occlusions, bifurcations, calcified lesions and diffuse disease. He is a regular TAVI operator and certified implanter for the Medtronic Evolute R and Edwards Sapien 3 transcatheter aortic valves. He participated in more than 130 MitraClip implantations in London and in the last few months back in Italy has also started transcatheter mitral treatments with clips, valves and direct annuloplasty. Professor Di Mario pioneered the use of intracoronary Doppler, pressure measurement, ultrasound and optical coherence tomography. These techniques have become the gold standard for physiological assessment of lesion severity and have revolutionised the technique of stent implantation with the use of high pressure dilatation which led to the universal application of this method in interventional cardiology. He is now applying these intravascular techniques for the guidance of implantation of fully bioabsorbable stents and optimal stent apposition across bifurcations and in complex lesions. He has led or participated in studies and trials to improve the technical success of recanalisation of chronic total occlusion and demonstrate its clinical usefulness. He cooperated with Dr Davies to the validation of iFR to assess lesion severity and discriminate the contribution of individual lesions, and with Dr Lyon in the intracoronary delivery of SERCA-2 genes via adenoviral vectors in the CUPID2 trial. He was Principal Investigator of the CARESS in AMI trial, a large multicentre trial showing that patients who receive fibrinolytic therapy for ST-elevation myocardial infarction benefit from early angioplasty. This trial and a subsequent meta-analysis have led to a change in the European Society of Cardiology and AHA/ACC Guidelines for treatment of STEMI patients. He is the PI and main recruiter of the Disrupt-CAD study with coronary lithotripsy delivered via dedicated balloons, due to be reported at ACC March 2017. Dr Andrew Sharp is a Consultant Interventional Cardiologist at the Royal Devon and Exeter Hospital and Honorary Senior Lecturer at the University of Exeter in South West England. He trained in Edinburgh, London and Milan, and was awarded a research MD for his work on the hypertensive heart whilst at Imperial College. He is current departmental lead in Exeter for cardiac cath labs, hypertension and cardiac research. He currently leads research studies in the areas of coronary physiology, pharmacological management of hypertension, renal denervation, intra-coronary imaging, complex PCI, aortic valve disease and pulmonary embolus.Dr Rasha Al-Lamee is an Interventional Cardiology Consultant at Imperial College Healthcare NHS Trust in London, UK. Dr Al-Lamee’s research interests are complex coronary intervention, coronary physiology and invasive intravascular assessment. She designed, conducted and led the ORBITA trial and is the lead author of the primary publication in The Lancet. At Imperial College, she is actively involved in the development and recruitment for a number of multi-centre clinical trials. Dr Al-Lamee has over 40 peer-reviewed publications and has presented at international Cardiology conferences worldwide throughout her clinical career. She studied at the University of Oxford and University College London. She went onto complete her training as a junior doctor on the Barts and the London Medical rotation before being appointed as a Specialist Registrar on the North West London Cardiology rotation in 2006. Dr Al-Lamee has twelve years of Cardiology experience and completed three years of Interventional Fellowship training at Hammersmith Hospital in London. She also spent a year training as an Interventional Fellow under the supervision of Professor Antonio Colombo in Milan. She completed specialist training in Cardiology in 2013. Dr Christopher Cook is a Medical Research Council Clinical Fellow at Imperial College London, undertaking a PhD in coronary physiology under the supervision of Dr Justin Davies. He studied Medicine at University College London (UCL) and graduated with Distinction (Clinical Medicine and Clinical Sciences) in his final MBBS Examinations in 2009. He achieved a First Class (Honours) Bachelor of Science degree in Physiology undertaking a period of research at The Hatter Cardiovascular Institute. He was awarded ‘The Dean’s List’ for outstanding performance in the Faculty of Life Sciences. In total he was awarded 17 prizes including the prestigious Gold Medal Medicine (proxime accessit). In 2014, he was awarded the Imperial Valve and Cardiovascular Course Young Investigator Prize. In 2015 he was awarded the inaugural EuroPCR’s Got Talent Award. In 2017 he was elected onto the EuroPCR Clinical Programme Committee. Prof Hitoshi Matsuo is currently President of Gifu Heart Center, and Clinical Visiting Professor of Medicine in Gifu University School of Medicine. He graduated from Jichi Medical School in 1986 and completed his residency in Gifu Prefectural Gifu Hospital. In 1987, during his residency period, Prof Hitoshi Matsuo spent one year at Johns Hopkins Medical Institutions in Baltimore as a research fellow in the Nuclear Medicine Department under the supervision of Professor Henry N Wagner Jr. From 1988, he returned to Gifu Prefectural Hospital where he dedicated clinical research work on physiology and interventional cardiology using nuclear medicine and pressure wires. He received an annual award of Japanese Society of Nuclear Medicine in 1995 and the Clinical Research Award of Japanese Society of Interventional Cardiology in 2004. Thereafter, he moved to Toyohashi Heart Center as co-director of the catheterization laboratory from 2007 and returned to Gifu as the Director of Cardiovascular Medicine in 2009. Dr Matsuo now participates and contributes to many international multi-center trials including DEFINE-FLAIR, the international multicenter FFRCT registry (ADVANCE registry), 3V-FFR FRIENDS study and FAVOR2 in both Europe and Japan. Juliet Nilsson is the Creative Director of Simple Education, the online cardiology educational platform aggregating content from key courses, global intuitions and leaders in the field of interventional cardiology. She received a Master’s in Art History with Honours from Edinburgh University before joining the Creative Development team at Lightyears, Stockholm in 1998. Juliet continued in creative development in Copenhagen for the trail blazing e-commerce bureau AHEAD, and then as International Creative Director for Caput Community Software Solutions. Following a role as Senior Consultant at Halcyon Gallery in London and Copenhagen, Juliet founded Vind & Våg Publishing House in 2013, a creative development agency. Juliet has published several books under her own imprint and is currently the founder & advisor to the Nordic Art Agency. Dr Sukhjinder Nijjer is a Consultant Cardiologist with a specialist interest in Coronary Intervention and the treatment of coronary artery disease. He works at both Chelsea & Westminster NHS Foundation Trust and Imperial College Healthcare NHS Trust. Dr Nijjer is also an Honorary Clinical Senior Lecturer at Imperial College. He has clinical research interests in coronary physiology and the treatment of acute coronary syndromes. He has a PhD awarded by Imperial College London in coronary blood flow and the use of stenting to treat complex stenoses. Clinically, he is specialises in interventional cardiology and he is skilled in coronary intervention and the application of coronary physiology and intravascular imaging. He has expertise in anti-platelets, optical coherence tomography and CT coronary angiography. He has specific research interests in coronary artery physiology and clinical trial design, and is working at the forefront of innovation in physiological assessment for coronary disease. He has presented his PhD research at the leading cardiology conferences around the world, including the European Society of Cardiology (ESC), Transcatheter Cardiovascular Therapeutics (TCT) and EuroPCR. He has won many awards and has over 70 high impact publications. Dr Ricardo Petraco is a NIHR Lecturer in Cardiology at Imperial College London, with a research interest in coronary physiology and interventional cardiology. He is also a Cardiology Specialist Registrar and Interventional Fellow at the Imperial College NHS Trust. After graduating in Brazil, he undertook his cardiology training in leading UK centres, including the Royal Brompton Hospital, St Mary’s Hospital and, currently, Hammersmith Hospital. He has been working with the coronary physiology group at Imperial since 2010 on the development of the novel instantaneous wave-Free Ratio (iFR). Dr Petraco’s work with iFR has led to the proposition of the Hybrid iFR-FFR approach and has established iFR’s close relationship with coronary flow reserve (CFR). Throughout his career, he has secured many research grants - CNPq grant for scientific initiation in Brazil (twice, 2000 and 2001); Imperial College Charity grant (2010); British Heart Foundation CRTF grant (2011) and Academy of Medical Sciences lecturer grant (2016) – and has published extensively in the field of coronary physiology. His interests in computer programming has led to the development of a software for automated analysis of coronary haemodynamics signals which is been used by many leading centres in the world. He has also proposed an algorithm for iFR calculation without the need for an ECG signal. His current research interests are on the development of methodologies to assess stenosis severity in situations of haemodynamic instability and on the understanding of how medical therapies modulate coronary resistance and flow. Dr Sayan Sen is a Consultant Interventional Cardiologist and NIHR Clinical Lecturer at Imperial College London. His research interests are dedicated to improving patient care. As such, they include the development and validation of new diagnostic tools, determining how the design of comparative efficacy studies can affect clinical use of competing therapies and the development and application of tools that permit a more patient centered approach to therapy. He studied Medicine at University College London (UCL), achieving a First Class (Honours) Bachelor of Science degree in Medical Sciences & Neuroscience in 2000 and graduated with distinction (Surgery) in his final MBBS Examinations in 2003. He trained as a junior doctor on the Hammersmith and UCL medical rotations prior to being appointed as a Cardiology Specialist Registrar in the North West London region in April 2006 and a NIHR clinical Lecturer in 2013. One of the themes of his research is to determine the need for potent vasodilators when assessing coronary stenosis severity. Working with Dr Justin Davies, Dr Sen’s PhD introduced and developed a new technique of stenosis evaluation (the instantaneous wave-free ratio, iFR). In addition to being the Principal Investigator of several first in man physiological studies, he was also the Medical Director of the DEFINE FLAIR trial – a global multi-centre randomized study that has recently demonstrated the non-inferiority of iFR to FFR for revascularisation decision-making in over 2500 patients. |
This essential guide is an educational activity intended for an international audience, specifically interventional cardiologists and cardiologists. However, other healthcare professionals involved in the care of coronary artery disease (CAD) patients will also find this topical.
This 2 day course general admission pass which covers registration, meals, and refreshments. After course free access to online course resources including powerpoint images, course videos, and links to other Simple Education resources.
Advances in Coronary Physiology and Imaging Co-Registration course provides all you need to know to understand the basics of coronary physiology and imaging and what you need to do to implement both using co-registration into the cardiac catheter laboratory.